Despite of global COVID 19 pandemic challenges we successfully completed our first Glucose clamping study
Successful completion of NABL inspection Mar 20 – Mar 21, 2021
Our Clinical path lab has been assessed and accredited in accordance with the standard ISO 15189:2012 "Medical laboratories - Requirements for quality and
competence"
MHRA BE Inspection 23 - 30 Nov 2021
Successful Completion of MHRA BE Inspection
(with NO Critical Observations)
2020
USFDA Inspection 20 Jan – 24 Jan 2020
Successfully completed USFDA inspection with no 483
Glucose clamping unit Jun 2020
Jeevan Scientific has established an exceptional and complex service portfolio of GLUCOSE CLAMPING TECHNIQUE PHASE I UNIT
2019
CDSCO Inspection 03 Dec – 04 Dec 2019
Successfully completed CDSCO renewal audit. Received renewal approval to our clinical & analytical facilities.
Successfully completed our 1st PMW study
Oct 2019
Successfully completed 1st Post menopausal women subject Pivotal BA/BE study.
USFDA inspection 15 Apr - 24 Apr 2019
Successfully completed USFDA inspection with no 483.
WHO inspection 04 Mar - 07 Mar 2019
Successfully completed WHO inspection without any major observations
200 BE studies - Feb 2019
Reached mark of 200 studies in a span of 2 years from the date of initiation of our first full scope BE study in Feb 2017
2018
Jan 09 -12, 2018 USFDA inspection
Successfully completed our First USFDA inspection to our Clinical Facility
2017
Feb 2017
Initiated our First full scope BE study
Jun 05 - 08, 2017
Successfully completed our First USFDA inspection to Bioanalytical facility. Concluded with no 483.
2016
Oct 2016
Inauguration Jeevan Scientific's New Clinical Facility with 132 bed capacity in Balanagar- Hyderabad
Dec 2016
Clinical facility inspected and approved by CDSCO
2015
Mar 2015
Bioanalytical facility inspected and approved by CDSCO
2014
Apr 2014
Dr. Rajendra Prasad has joined as a CEO & Executive Director
Nov 2014
Listed in BSE
Dec 2014
Inauguration of Jeevan Scientific New Corporate and Bioanalytical facility
